NCT06662305

Brief Summary

High school students who want to quit vaping will be randomized to receive the Kick-Nic! app or a control NCI website to determine the efficacy of the app for vaping cessation. Participants will be screened for eligibility, then go through an 8 week treatment period where they will be given access to use the Kick-Nic! app or referred to the NCI Quit Vaping website. This will be followed by 1, 2, 3, and 6 month follow up visits. Qualitative interviews with participants and school staff will also be conducted to obtain feedback on the app and best ways to implement/disseminate the app. Abstinence rates will be assessed biweekly during treatment including at end of treatment (EOT), and then at 1, 2, 3 and 6 month follow ups (FU). Biochemical verification (salivary cotinine \< 30 ng.ml) of self-reports of abstinence will be conducted at EOT and 6-month FU.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
306

participants targeted

Target at P75+ for phase_2

Timeline
40mo left

Started Jan 2025

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Jan 2025Aug 2029

First Submitted

Initial submission to the registry

October 16, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 28, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

January 16, 2025

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2029

Last Updated

January 28, 2026

Status Verified

January 1, 2026

Enrollment Period

4.6 years

First QC Date

October 16, 2024

Last Update Submit

January 26, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Timeline Follow Back (self-report) with saliva cotinine (biochemical verification) at 6 month follow up.

    Timeline Follow Back (self-report) determining 7-day point prevalence of e-cigarette use confirmed by saliva cotinine \<30ng/mL at 6 month follow up visit.

    6 month follow up study visit.

Secondary Outcomes (2)

  • Timeline Follow Back (self-report) with saliva cotinine (biochemical verification) at End of Treatment (EOT).

    EOT (8 weeks).

  • Timeline Follow Back (self-report) at EOT, 3, and 6 month follow up

    EOT (8 weeks), 3 month follow up, and 6 month follow up.

Study Arms (2)

ACTIVE

EXPERIMENTAL

Participants in the active group will be given access to the Kick-Nic! app to use for vaping cessation.

Behavioral: Kick-Nic! mobile phone application

CONTROL

ACTIVE COMPARATOR

Participants in the control group will be referred to the NCI Quit Vaping website.

Behavioral: NCI Quit Vaping website

Interventions

The Kick-Nic! app has seven modules that cover core CBT strategies using skills, graphic illustrations, and interactive components to help adolescents quit using e-cigarettes.

ACTIVE

The NCI webpage provides quitting tobacco resources for youth, including for e-cigarettes. The information provided is similar to the CBT skills modeled by the Kick-Nic! app.

CONTROL

Eligibility Criteria

Age13 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • high school aged youth (13-19 years old),
  • regular current (past month) e-cig users using nicotine-containing e-cigs at least 1 day/week.
  • want to quit using e-cigarettes.
  • have a smartphone with data/WIFI plan in order to access and utilize the KickNic! app

You may not qualify if:

  • Those who have non-stable (\<2 months) use of anxiolytics, antidepressants, and other psychostimulants or have a history of psychosis or any significant current psychiatric/medical condition that would increase risk will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale University School of Medicine (Connecticut Mental Health Center)

New Haven, Connecticut, 06519, United States

RECRUITING

MeSH Terms

Conditions

Vaping

Condition Hierarchy (Ancestors)

SmokingBehavior

Study Officials

  • Suchitra Krishnan-Sarin, Ph.D.

    Yale University School of Medicine, Dept of Psychiatry

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized into an ACTIVE group or CONTROL group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2024

First Posted

October 28, 2024

Study Start

January 16, 2025

Primary Completion (Estimated)

August 31, 2029

Study Completion (Estimated)

August 31, 2029

Last Updated

January 28, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

De-identified individual participant data that underlie results in a publication may be shared with other researchers.

Locations